873 top medical experts on Primary Myelofibrosis across 37 countries and 35 U.S. states, including 841 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by cytokines arising from the abnormal clone.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Myeloproliferative Disorders (1,660).
  4. Clinical Trials ClinicalTrials.gov : at least 244 including 19 Active, 113 Completed, 50 Recruiting


  

        

                    


    Computing Expert Listing ...

);